TipRanks
Go Ultimate75% OFF

Kaye Foster-Cheek Insider Profile

4 Followers

Kaye Foster-Cheek, Director at Agios Pharma, holds 12.48K shares in Agios Pharma (Ticker: AGIO), holds ― shares in Prime Medicine, Inc. (Ticker: PRME), holds 5.80K shares in Johnson & Johnson (Ticker: JNJ).

Kaye Foster-Cheek's Trading History

AGIO
Agios Pharma
Jun 23, 2026DirectorUninformative Buy96.19K$367.15K
JNJ
Johnson & Johnson
Jan 04, 2010VP HRUninformative Buy―$1.60M
ONXX
Onyx Pharma
――――
PRME
Prime Medicine, Inc.
―Director――

You May Also Like

Kaye Foster-Cheek insider profile FAQ

What is the percentage of profitable transactions made by Kaye Foster-Cheek?
The percentage of profitable transactions made by Kaye Foster-Cheek is 0%.
What is the average return per transaction made by Kaye Foster-Cheek?
The average return per transaction made by Kaye Foster-Cheek is -23.80%.
What stocks does Kaye Foster-Cheek hold?
Kaye Foster-Cheek holds: AGIO, PRME, JNJ, ONXX stocks.
What was Kaye Foster-Cheek’s latest transaction?
Kaye Foster-Cheek’s latest transaction was an Uninformative Buy of $96.19K.
What was Kaye Foster-Cheek's most profitable transaction?
Kaye Foster-Cheek’s most profitable transaction was an Informative Sell of AGIO stock on March 7, 2024. The return on the trade was -3.20%.
What is Kaye Foster-Cheek's role in Agios Pharma?
Kaye Foster-Cheek's role in Agios Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.